Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)

2.71
Delayed Data
As of Aug 14
 -0.01 / -0.37%
Today’s Change
2.52
Today|||52-Week Range
54.60
-82.33%
Year-to-Date
Sonnet BioTherapeutics reports Q3 results
Aug 14 / Seeking Alpha - Paid Partner Content
AAAPL, FB among premarket gainers
Jul 31 / Seeking Alpha - Paid Partner Content
PINS, ZN, KNDI and KODK among midday movers
Jul 31 / Seeking Alpha - Paid Partner Content
AAPL, FB among premarket gainers
Jul 31 / Seeking Alpha - Paid Partner Content
Sonnet BioTherapeutics leads healthcare gainers; ThermoGenesis and Edesa Biotech among losers
Jul 31 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close2.72
Today’s open2.65
Day’s range2.58 - 2.72
Volume17,006
Average volume (3 months)2,483,725
Market cap$37.0M
Data as of 4:47pm ET, 08/14/2020

Growth & Valuation

Earnings growth (last year)-29.04%
Earnings growth (this year)--
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-25.78%
P/E ratio--
Price/Sales0.14
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 18, 2020
EPS forecast (this quarter)-$8.32
Annual revenue (last year)$30.1M
Annual profit (last year)-$17.7M
Net profit margin-56.53%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts